ARMC
PRVB

American Research & Management Company’s Provention Bio, Inc. Common Stock PRVB Stock Holding History

American Research & Management Company’s Portfolio PRVB Stock Details PRVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-400
Closed -$6K – 346
2019
Q4 		$6K Hold
400
– – ﹤0.01% 286
2019
Q3 		$3K Buy
+400
New +$4.04K ﹤0.01% 319

Other funds holding PRVB

Perceptive Advisors
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return

American Research & Management Company's PRVB Position: Q1 2020 in Review

American Research & Management Company sold out of Provention Bio, Inc. Common Stock (PRVB) in Q1 2020, closing a stake of 400 shares — an estimated $6K sold.

American Research & Management Company first reported a position in PRVB in Q3 2019 and held it in 2 quarters. The position peaked at $6K in Q4 2019. 63 funds tracked by Wall St. Rank hold PRVB as of Q1 2020.

  • American Research & Management Company reported no remaining Provention Bio, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • American Research & Management Company sold 400 Provention Bio, Inc. Common Stock shares in Q1 2020, an estimated $6K.
  • American Research & Management Company first reported a position in Provention Bio, Inc. Common Stock in Q3 2019 and held it in 2 quarters.
  • American Research & Management Company's Provention Bio, Inc. Common Stock position peaked at $6K in Q4 2019.
  • 63 funds tracked by Wall St. Rank held Provention Bio, Inc. Common Stock as of Q1 2020.

Based on American Research & Management Company's 13F filing for Q1 2020, filed 28 Apr 2020.